Institut für Pathologie, Ruhr-Universität Bochum, Bürkle-de-la-Camp Platz 1, 44789 Bochum, Germany.
Dtsch Arztebl Int. 2010 Oct;107(43):760-6. doi: 10.3238/arztebl.2010.0760. Epub 2010 Oct 29.
The widespread application of molecular methods in pathology has yielded steady advances in our understanding of the origins of colorectal carcinoma. Multiple pathways of carcinogenesis have been demonstrated on the molecular level and visualized on the histopathological level. The WHO has accordingly proposed a number of new designations and terms, particularly for precursor lesions, in order to establish a uniform standard for clinical diagnosis. These should be put into practice at once.
In this article, we explain the concept of intraepithelial neoplasia, which replaces the older concept of dysplasia. Moreover, we use this concept in describing a new mechanism of carcinogenesis for colorectal carcinoma, on the basis of a selective review of the literature. We estimate the frequency of precursor lesions according to the new concept using data from our own patient collective. Finally, we discuss the clinical consequences, which have been addressed in the German S3 guideline for colorectal carcinoma.
The new type of precursor lesion, called "sessile serrated adenoma" (SSA), accounts for some 7% of all adenomas in our patient collective and is usually found in the right hemicolon. Traditional serrated adenomas (TSA) made up 1% to 3% of our cases and were found mainly in the left hemicolon and rectum.
Our observations on the frequency and location of serrated adenomas accord with the initial findings published in the international literature. In view of the risk that serrated lesions will progress more rapidly, it is recommended that they should be completely removed, with follow-up at a short interval thereafter (three years according to the German S3 guidelines).
分子方法在病理学中的广泛应用使得我们对结直肠癌的起源有了不断深入的理解。在分子水平上已经证明了多种致癌途径,并在组织病理学水平上得到了证实。世界卫生组织因此提出了一些新的命名和术语,特别是针对前体病变,以便为临床诊断建立一个统一的标准。这些标准应立即付诸实施。
本文通过对文献的选择性回顾,解释了取代旧概念的上皮内瘤变的概念。此外,我们还利用这一概念描述了结直肠癌发生的一种新的致癌机制。我们根据新的概念,利用我们自己的患者群体的数据来估计前体病变的频率。最后,我们讨论了德国结直肠癌 S3 指南中所涉及的临床后果。
我们的患者群体中,新的前体病变类型,即“无蒂锯齿状腺瘤”(SSA),占所有腺瘤的 7%左右,通常发生在右半结肠。传统锯齿状腺瘤(TSA)占我们病例的 1%至 3%,主要发生在左半结肠和直肠。
我们对锯齿状腺瘤的频率和位置的观察结果与国际文献中的初步发现一致。鉴于锯齿状病变进展更快的风险,建议完全切除,并在其后进行短期随访(根据德国 S3 指南为三年)。